Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRMS.L Regulatory News (RMS)

  • There is currently no data for RMS

Director Dealing

11 Jan 2021 18:26

RNS Number : 3133L
Remote Monitored Systems PLC
11 January 2021
 

11 January 2021

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Remote Monitored Systems plc ("RMS" or the "Company")

Director Dealing

Remote Monitored Systems plc ("RMS" or the "Company") announces that it has been notified today that on 7 January and 11 January, Trevor Brown, Non-Executive Director of the Company, has sold, in aggregate, 24,000,000 ordinary shares in the Company at an aggregate price of approximately 2.7 pence per share.

Following this transaction, Trevor Brown holds no shares in the Company. He continues to hold 14,801,756 share options at an exercise price of 1.4 pence per share.

- ENDS -

 

ENQUIRIES:

Remote Monitored Systems plc

John Richardson (Executive Director) +44 7751 118916

 

SP Angel Corporate Finance LLP +44 20 3470 0470

Nominated Adviser and Joint Broker

Stuart Gledhill

Caroline Rowe

 

Peterhouse Capital Limited +44 20 7469 0930

Joint Broker

Lucy Williams

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Brown

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Director

 

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Remote Monitored Systems plc

b)

 

LEI

 

213800VR2P5DDQHYZO48

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 0.01 pence each    

 

GB00BFX0ZN92

b)

 

Nature of the transactions

 

Sale of shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

a) 2.9p

 

b) 2.6p

 

 

Volume(s)

10,000,000

 

14,000,000 

d)

 

Aggregated information

- Aggregated volume

- Price

- Principal amount

 

 

Single transactions as in 4 c) above    

2.7p

24,000,000

e)

 

Dates of the transaction

 

a) 7 January 2021

b) 11 January 2021

 

 

 

f)

Place of transaction

AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHZZGMMRMDGMZM
Date   Source Headline
16th Dec 20202:11 pmRNSPharm 2 Farm Update
15th Dec 202011:44 amRNSPharm 2 Farm Update
14th Dec 20207:00 amRNSPharm 2 Farm Update
11th Dec 202012:00 pmRNSPharm 2 Farm Update
30th Nov 20204:36 pmRNSPrice Monitoring Extension
30th Nov 20202:06 pmRNSSecond Price Monitoring Extn
30th Nov 20202:00 pmRNSPrice Monitoring Extension
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20202:00 pmRNSPrice Monitoring Extension
26th Nov 20209:05 amRNSSecond Price Monitoring Extn
26th Nov 20209:00 amRNSPrice Monitoring Extension
26th Nov 20207:00 amRNSUpdate on P2F
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
19th Nov 20209:05 amRNSSecond Price Monitoring Extn
19th Nov 20209:00 amRNSPrice Monitoring Extension
18th Nov 20206:07 pmRNSHolding(s) in Company
18th Nov 20205:52 pmRNSDirector Dealing
18th Nov 20209:05 amRNSSecond Price Monitoring Extn
18th Nov 20209:00 amRNSPrice Monitoring Extension
17th Nov 20205:27 pmRNSHolding(s) in Company
17th Nov 20202:05 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
17th Nov 20209:06 amRNSSecond Price Monitoring Extn
17th Nov 20209:00 amRNSPrice Monitoring Extension
17th Nov 20207:01 amRNSHolding(s) in Company
17th Nov 20207:00 amRNSDirector Dealing
16th Nov 20202:06 pmRNSSecond Price Monitoring Extn
16th Nov 20202:01 pmRNSPrice Monitoring Extension
16th Nov 20209:05 amRNSSecond Price Monitoring Extn
16th Nov 20209:00 amRNSPrice Monitoring Extension
16th Nov 20207:30 amRNSPharm 2 Farm Update and Issue of Equity
16th Nov 20207:00 amRNSPharm 2 Farm Update
13th Nov 20204:41 pmRNSSecond Price Monitoring Extn
13th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Nov 202011:06 amRNSSecond Price Monitoring Extn
13th Nov 202011:00 amRNSPrice Monitoring Extension
13th Nov 20209:06 amRNSSecond Price Monitoring Extn
13th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20204:41 pmRNSSecond Price Monitoring Extn
12th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20203:28 pmRNSExercise of Warrants and Funding Update
12th Nov 202011:40 amRNSHolding(s) in Company
12th Nov 202011:06 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension
11th Nov 20204:41 pmRNSSecond Price Monitoring Extn
11th Nov 20204:36 pmRNSPrice Monitoring Extension
11th Nov 20202:05 pmRNSSecond Price Monitoring Extn
11th Nov 20202:00 pmRNSPrice Monitoring Extension
11th Nov 202010:59 amRNSPharm 2 Farm Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.